Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants of Liang Qu et al

Published: 23 March 2022| Version 1 | DOI: 10.17632/vp2fskswfv.1
Contributor:
Liang Qu

Description

1. Table S1. The sequences of the circRNA-RBD produced via Group I Intron. 2. Table S2. The sequences of the circRNA-RBD produced via T4 RNA ligases. 3. Table S3. The sequences of the mRNA-RBD-Delta. 4. Table S4. The peptide sequences of the RBD-Delta antigen. 5. Table S5. The peptide sequences of the RBD antigen.

Files

Institutions

Peking University

Categories

Immunology

Licence